Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

WALGREENS BOOTS ALLIANCE (WBA)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 10/16 10:00:00 pm
76.28 USD   +2.09%
10/15WALGREENS BOOTS : Buying pressure
10/12RITE AID : Deal Lifts Walgreens Pharmacy
DJ
10/11WALGREENS BOOTS : Sales Growth Falls Short -- 2nd Update
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Walgreens Boots Alliance : Reports Soaring Profit But Sales Miss Expectations

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/11/2018 | 01:57pm CEST

By Kimberly Chin

Walgreens Boots Alliance Inc. (WBA) reported stronger sales and profits in its fourth quarter Thursday but the sales missed analysts' expectations.

The Deerfield, Ill.-based company said net income rose 88.5% to $1.5 billion, or $1.55 a share, from the same period a year ago. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts polled by Refinitiv.

Sales rose 10.9% to $33.44 billion. Analysts had expected the company to report $33.78 billion in sales.

Walgreen's shares fell 2.5% to $70.50 in premarket trading. The stock is flat for the year to date.

Comparable pharmacy-sales growth in the U.S. rose 1.3% in its latest quarter on higher volume, though the company continues to cope with reimbursement pressures and the impact of generic drugs. Comparable pharmacy sales decreased 3.4% abroad.

Comparable retail sales fell 1.9% in the U.S. while it fell 0.9% on a constant-currency basis internationally.

The drugstore chain also gave earnings guidance for the fiscal 2019. It expects adjusted earnings growth between 7% to 12% at constant currency rates, for adjusted earnings per share in the range of $6.40 to $6.70.

Walgreens has expanded in recent years by merging with European drug wholesaler Alliance Boots and buying up stores from rival Rite Aid Corp. The company, whose roots date back to 1901, has more than 13,200 stores across 11 countries.

Write to Kimberly Chin at kimberly.chin@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE
10/12RITE AID : Deal Lifts Walgreens Pharmacy
DJ
10/11WALGREENS BOOTS ALLIANCE : Management's discussion and analysis of financial con..
AQ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short -- 2nd Update
DJ
10/11LABORATORY OF AMERICA : Walgreens and LabCorp to Open at Least 600 LabCorp at Wa..
AQ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short--Update
DJ
10/11WALGREENS BOOTS ALLIANCE : Reports Soaring Profit But Sales Miss Expectations
DJ
10/11WALGREENS BOOTS ALLIANCE : tops 4Q expectations, helped by Rite Aid deal
AQ
10/11WALGREENS BOOTS ALLIANCE, INC. : Results of Operations and Financial Condition, ..
AQ
10/11WALGREENS BOOTS ALLIANCE : Reports Fiscal Year 2018 Results
BU
10/11WALGREENS BOOTS ALLIANCE : Annual results
CO
More news
News from SeekingAlpha
10/16AmerisourceBergen perks up on chance of WBA deal; shares up 4% 
10/16Beat The Recession With Dividends - Part 3 
10/16Jerry Maguire Stock Market 
10/15FDA issues new guidance aimed at more efficient drug development 
10/15YEP, THE FED'S GOING TOO FAR, AND TR : Analysis 
Financials ($)
Sales 2019 138 B
EBIT 2019 7 993 M
Net income 2019 5 450 M
Debt 2019 12 869 M
Yield 2019 2,34%
P/E ratio 2019 12,94
P/E ratio 2020 11,73
EV / Sales 2019 0,60x
EV / Sales 2020 0,57x
Capitalization 69 764 M
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 76,1 $
Spread / Average Target 1,9%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
Alexander W. Gourlay President & Co-Chief Operating Officer
Richard M. Ashworth President-Operations
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE1.21%69 764
EXPRESS SCRIPTS HOLDING CO25.29%53 002
MCKESSON CORPORATION-15.76%26 128
AMERISOURCEBERGEN-2.48%19 143
CARDINAL HEALTH-15.73%15 482
WELCIA HOLDINGS CO LTD20.41%5 514